BIDU-SW
09888
JD HEALTH
06618
ALI HEALTH
00241
NTES-S
09999
BEKE-W
02423
(FY)Jun 30, 2024 | (Q6)Dec 31, 2023 | (Q3)Sep 30, 2023 | (FY)Jun 30, 2023 | (Q9)Mar 31, 2023 | (Q6)Dec 31, 2022 | (Q3)Sep 30, 2022 | (FY)Jun 30, 2022 | (Q9)Mar 31, 2022 | (Q6)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 16.15%5.85B | 19.87%2.91B | 44.61%1.43B | 614.11%5.03B | 2,906.37%3.94B | 4,646.62%2.43B | 4,150.35%988.29M | 438.46%705.04M | 18.69%131.11M | -38.26%51.11M |
Operating income | 16.15%5.85B | 19.87%2.91B | 44.61%1.43B | 614.11%5.03B | 2,906.37%3.94B | 4,646.62%2.43B | 4,150.35%988.29M | 438.46%705.04M | 18.69%131.11M | -38.26%51.11M |
Cost of sales | -15.73%-5.82B | -19.44%-2.89B | -44.32%-1.42B | -626.27%-5.02B | -3,093.83%-3.93B | -5,281.81%-2.42B | -4,612.42%-984.57M | -624.73%-691.85M | -45.23%-123.11M | 28.13%-45M |
Operating expenses | -15.73%-5.82B | -19.44%-2.89B | -44.32%-1.42B | -626.27%-5.02B | -3,093.83%-3.93B | -5,281.81%-2.42B | -4,612.42%-984.57M | -624.73%-691.85M | -45.23%-123.11M | 28.13%-45M |
Gross profit | 222.70%32.52M | 253.59%15.86M | 121.07%8.24M | -23.60%10.08M | 22.33%9.79M | -26.68%4.48M | 57.95%3.73M | -62.82%13.19M | -68.86%8M | -69.68%6.12M |
Administrative expenses | -12.69%-26.92M | 22.37%-19.03M | 16.84%-9.55M | 38.69%-23.89M | -1.90%-31.97M | -7.59%-24.52M | -6.86%-11.48M | 8.76%-38.96M | 4.99%-31.37M | -4.62%-22.79M |
Profit from asset sales | --11.25M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Revaluation surplus | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.11%475K | ---- |
-Changes in the fair value of financial assets | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | -78.11%475K | ---- |
Impairment and provision | -291.03%-14.57M | ---- | ---- | 111.81%7.63M | --7.25M | --7.25M | ---- | 115.33%3.6M | ---- | ---- |
-Impairment of property, machinery and equipment | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---5.92M | ---- | ---- |
-Other impairment is provision | -291.03%-14.57M | ---- | ---- | -19.89%7.63M | --7.25M | --7.25M | ---- | 140.54%9.52M | ---- | ---- |
Special items of operating profit | -178.92%-9.91M | 16.53%-1.63M | 66.13%-1.42M | 30.11%12.56M | -23.01%5.81M | -127.21%-1.95M | -241.95%-4.19M | -15.20%9.66M | 20.95%7.55M | 71.80%7.16M |
Operating profit | -219.65%-7.63M | 67.38%-4.8M | 77.16%-2.73M | 150.95%6.38M | 40.61%-9.11M | -54.83%-14.73M | -119.85%-11.94M | 35.22%-12.52M | -1,502.47%-15.34M | -101.89%-9.51M |
Financing cost | 79.03%-186K | 22.15%-573K | 31.20%-322K | 46.21%-887K | 27.88%-851K | 12.90%-736K | 1.89%-468K | 41.81%-1.65M | 45.75%-1.18M | 44.88%-845K |
Earning before tax | -242.37%-7.82M | 65.23%-5.38M | 75.42%-3.05M | 138.76%5.49M | 39.70%-9.96M | -49.30%-15.47M | -110.02%-12.41M | 36.07%-14.17M | -1,428.49%-16.52M | -65.86%-10.36M |
Tax | 142.18%1.17M | 36.01%-1.17M | 90.58%-141K | -268.55%-2.78M | -35.81%-2.25M | -72.44%-1.83M | -305.69%-1.5M | 121.08%1.65M | 36.67%-1.65M | 60.47%-1.06M |
After-tax profit from continuing operations | -345.22%-6.64M | 62.13%-6.55M | 77.05%-3.19M | 121.65%2.71M | 32.83%-12.21M | -51.46%-17.3M | -121.52%-13.91M | 58.26%-12.52M | -392.44%-18.18M | -27.84%-11.42M |
After-tax profit from non-continuing business | -66.00%-12.26M | ---- | ---- | ---7.39M | ---- | ---- | ---- | ---- | ---- | ---- |
Earning after tax | -304.08%-18.91M | 62.13%-6.55M | 77.05%-3.19M | 62.61%-4.68M | 32.83%-12.21M | -51.46%-17.3M | -121.52%-13.91M | 58.26%-12.52M | -392.44%-18.18M | -27.84%-11.42M |
Minority shareholders should account for profits from continuing business | 92.77%-444K | ---- | ---- | ---6.14M | ---- | ---- | ---- | ---- | ---- | ---- |
Minority profit | 92.77%-444K | 86.77%-145K | 81.46%-124K | -72.80%-6.14M | 54.24%-954K | -284.56%-1.1M | -715.85%-669K | -3,015.79%-3.55M | -677.99%-2.09M | -4.01%-285K |
Shareholders should account for profits from continuing business | -170.07%-6.2M | ---- | ---- | --8.85M | ---- | ---- | ---- | ---- | ---- | ---- |
Shareholders should account for profits from non-continuing business | -66.00%-12.26M | ---- | ---- | ---7.39M | ---- | ---- | ---- | ---- | ---- | ---- |
Profit attributable to shareholders | -1,365.46%-18.46M | 60.47%-6.41M | 76.83%-3.07M | 116.28%1.46M | 30.06%-11.25M | -45.49%-16.2M | -113.65%-13.24M | 69.99%-8.96M | -370.08%-16.09M | -28.59%-11.14M |
Basic earnings per share | -1,369.23%-0.0495 | 60.42%-0.0171 | 76.77%-0.0082 | 116.32%0.0039 | 28.57%-0.0015 | -2,780.00%-0.0432 | -4,312.50%-0.0353 | -497.50%-0.0239 | -320.00%-0.0021 | -25.00%-0.0015 |
Diluted earnings per share | -1,369.23%-0.0495 | 60.42%-0.0171 | 76.77%-0.0082 | 116.32%0.0039 | 28.57%-0.0015 | -2,780.00%-0.0432 | -4,312.50%-0.0353 | -497.50%-0.0239 | -320.00%-0.0021 | -25.00%-0.0015 |
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Audit Opinions | Unqualified Opinion | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- |
Auditor | Tianjian International Certified Public Accountants Co., Ltd. | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- | -- | Shin-Ei Zhonghe (Hong Kong) Certified Public Accountants Limited | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.